Hostname: page-component-cd9895bd7-7cvxr Total loading time: 0 Render date: 2024-12-23T00:02:38.675Z Has data issue: false hasContentIssue false
  • English
  • Français

Ethnic and cultural factors in psychopharmacology

Published online by Cambridge University Press:  02 January 2018

Dinesh Bhugra  and
Kamaldeep Bhui
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Barring a few exceptions (such as rauwolfia), most of the psychiatric medications have been developed in the West, especially the USA, the UK and Europe. Their safety trials have been conducted in the populations living in these parts of the world. Although these drugs are used all over the world there is a limited research to determine accurate pharmacodynamic and pharmacokinetic profiles across different ethnic groups. Hence, clinicians usually adopt a ‘universalist style’ (seeing every condition and treatment as similar) of managing psychiatric illnesses, but this appears to neglect the information from the emerging literature which advocates a relativist approach to pharmacotherapy (see Lin et al 1995 for review). Anthropologists have encountered ‘phenomenological absolutism’ in a general tendency of people from one culture to perceive and value other cultures in terms unconsciously based upon their own, but phenomenologically experienced as absolute and universally applicable (also known as ethnocentrism). In addition to ethno-biological determinants of drug response, there are significant cultural factors: the concurrent use of pluralistic health systems, alternative therapies and folk remedies which might support, hinder or complicate pharmacotherapy and treatment adherence. In this paper we highlight some key factors of which clinicians need to be aware. These include pharmacodynamic and pharmacokinetic principles, and application of these principles in pharmacological management of psychiatric conditions. Ethnic differences in pharmacodynamics are most clearly demonstrated in the greater sensitivity to a variety of drugs in Caucasians than in Asians or in African–Caribbeans.

Type
Research Article
Information
Advances in Psychiatric Treatment , Volume 5 , Issue 2 , March 1999 , pp. 89 - 95
Copyright
Copyright © The Royal College of Psychiatrists 1999 

References

Allen, J., Rack, P. & Vaddadi, K. (1977) Differences in the effects of clomipramine on English and Asian volunteers. Postgraduate Medical Journal, 53, 79–86.Google Scholar
Binder, E. & Levy, R. (1981) Extrapyramidal reactions in Asians. American Journal of Psychiatry, 138, 1243–1244.Google ScholarPubMed
Chang, S. S., Chen, T.-Y., Lee, C. A. et al (1987) Lithium plasma reduced haloperidol/haloperidol ratios in Chinese patients. Biological Psychiatry, 22, 1406–1408.Google Scholar
Chang, S. S., Jann, M., Hwu, H.-G. et al (1991) Ethnic comparison of haloperidol and reduced haloperidol plasma levels: Taiwan Chinese versus American non-Chinese. Journal of the Formosan Medical Association, 90, 572–578.Google Scholar
Dawkins, K. (1996) The interaction of ethnicity, socio-cultural factors and gender in clinical psychopharmacology. Psychopharmac Bulletin, 32, 283–289.Google Scholar
Dimsdale, J., Ziegler, M. & Graham, R. (1988) The effect of hypertension sodium and race in isoprorenol sensitivity. Clinical and Experimental Hypertension, A10, 747–756.Google Scholar
Escobar, J. & Tuacon, V. (1980) Antidepressant agents in a cross cultural study. Psychopharmacology Bulletin, 16, 49–52.Google Scholar
Frackiewicz, E., Stannek, J., Herrara, J. et al (1997) Ethnicity and antipsychotic response. Annals of Pharmacotherapy, 31, 1360–1369.Google Scholar
Gaviria, M., Gill, A. & Javaid, J. (1986) Nortriptyline kinetics in Hispanic and Anglo subjects. Journal of Clinical Psychopharmacology, 6, 227–231.Google Scholar
Ghoneim, M., Kortilla, K., Chiang, C.-K. et al (1981) Diazepam effects and kinetics in Caucasians and Orientals. Clinical Pharmacology and Therapeutics, 29, 749–756.Google Scholar
Hu, W., Lee, C., Yang, Y. et al (1983) Imipramine plasma levels and clinical response. Bulletin of the Chinese Society of Neurology and Psychiatry, 9, 40–49.Google Scholar
Jann, M., Chang, W., Davis, C. et al (1989) Haloperidol and reduced haloperidol plasma levels in Chinese vs non Chinese psychiatric patients. Psychiatry Research, 30, 45–52.Google Scholar
Jann, M., Lam, Y. & Chang, W. (1993) Haloperidol and reduced haloperidol plasma concentration in different ethnic populations and inter individual variabilities in haloperidol metabolism. In Psychopharmacology and Psychobiology of Ethnicity. (eds Lin, K.-M., Poland, R. & Nakasaki, G.) pp. 133–152. Washington, DC: APA Press.Google Scholar
Kilow, W. (1982) Ethnic differences in drug metabolism. Clinical Pharmacokinetics, 71, 373–400.Google Scholar
Kishimoto, A. & Hollister, L. (1984) Nortriptyline kinetics in Japanese and Americans. Journal of Clinical Psychopharmacology, 4, 171–172.Google Scholar
Kumana, C., Lauder, I., Chan, M. et al (1987) Differences in diazepam pharmacokinetics in Chinese and white Caucasians. European Journal of Clinical Pharmacology, 32, 211–215.Google Scholar
Lewis, P., Rack, P., Vaddadi, K. et al (1980) Ethnic differences in drug response. Postgraduate Medical Journal, 56, 46–49.Google Scholar
Lieberman, J., Yunis, J., Egla, E. et al (1990) HLA – 1338, DR4, DRW 3 and Clozapine induced agranulocytosis in Jewish patients with schizophrenia. Archives of Chemical Psychiatry, 47, 945–948.Google Scholar
Lin, K.-M. (1996) Psychopharmacology in cross-cultural psychiatry. Mount Sinai Journal of Medicine, 63, 283–284.Google ScholarPubMed
Lin, K.-M., Lau, J., Smith, R. et al (1988) Comparison of alprazolam plasma levels and behavioural effects in normal Asian and Caucasian male volunteers. Psychopharmacology, 96, 365–369.Google Scholar
Lin, K.-M., Poland, R., Nuccio, I. et al (1989) Longitudinal assessment of haloperidol dosage and serum concentrations in Asian and Caucasian schizophrenic patients. American Journal of Psychiatry, 146, 1307–1311.Google Scholar
Lin, K.-M., Poland, R. & Nakasaki, G. (eds) (1993) Psychopharmacology and Psychobiology of Ethnicity. Washington, DC: APA Press.Google Scholar
Lin, K.-M., Poland, R. & Anderson, D. (1995) Psychopharmacology, ethnicity and culture. Transcultural Psychiatric Research Review, 32, 3–40.Google Scholar
Office of Population Censuses and Surveys (1992) County Monitor. London: HMSO.Google Scholar
Pi, E., Simpson, G. & Cooper, T. (1986) Pharmacokinetics of desiprmaine in Caucasian and Asian volunteers. American Journal of Psychiatry, 143, 1174–1176.Google ScholarPubMed
Pi, E., Tran-Johnson, T., Walker, N. et al (1989) Pharmacokinetics of desipramine in Caucasian and Asian volunteers. Psychopharmacology Bulletin, 25, 483–487.Google Scholar
Rudorfer, E., Lam, E., Chang, W. et al (1984) Desipramine pharmacokinetics in Chinese and Caucasian volunteers. British Journal of Clinical Pharmacology, 17, 433–440.CrossRefGoogle ScholarPubMed
Silver, B., Lin, K.-M. & Poland, R. (1993) Ethnicity and pharmacology of tricyclic antidepressants. In Psychopharmacology and Psychobiology of Ethnicity. (eds Lin, K.-M., Poland, R. & Nakasaki, G.) pp. 61–89. Washington, DC: APA Press.Google Scholar
Smith, M. & Mendoza, R. (1996) Ethnicity and pharmacogenetics. Mount Sinai Journal of Medicine, 63, 285–290.Google Scholar
Westermeyer, J. (1989) Psychiatric Care of Migrants. Washington, DC: APA Press.Google Scholar
Yamashita, I. & Asano, Y. (1979) Tricyclic antidepressants. Psychopharmacology Bulletin, 15, 40–41.Google Scholar
Zhang, Y., Reviriego, J., Lou, Y. et al (1990) Diazepam metabolism in native Chinese poor and extensive hydroxylators of S-mephenytoin. Clinical Pharmacology and Therapeutics, 48, 496–502.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.